In the past several years, the united kingdom has witnessed a revolution in health-related bodyweight‑decline treatments — within the introduction of semaglutide (Wegovy®) for the developing popularity of tirzepatide (Mounjaro®). Now, another name is drawing interest in both clinical and public w